Eledon Pharmaceuticals, Inc.(ELDN)
Biotechnology
Antibody Engineering (mAbs, bispecifics, ADCs)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-10-31 | BIOTECHNOLOGY VALUE FUND L P Other | Purchase | +4,754,549 | -83.88%838,507 | $3.65 | $17,349,349 | View SEC filing | |
| 2024-05-13 | BIOTECHNOLOGY VALUE FUND L P Other | Purchase | +7,859,378 | -80.58%452,528 | N/A | N/A | View SEC filing | |
| 2023-05-09 | BIOTECHNOLOGY VALUE FUND L P Other | Purchase | +11,565,180 | -55.82%563,270 | N/A | N/A | View SEC filing | |
| 2022-11-23 | Perrin Steven President | Purchase | +1,000 | +100.00%1,000 | $2.60 | $2,597 | View SEC filing | |
| 2021-12-21 | Gros David-Alexandre C Chief Executive Officer | Purchase | +2,000 | +28.57%9,000 | $4.48 | $8,960 | View SEC filing | |
| 2021-08-19 | Gros David-Alexandre C Chief Executive Officer | Purchase | +4,000 | +133.33%7,000 | $6.21 | $24,840 | View SEC filing | |
| 2021-06-14 | Little Paul Sean CHIEF FINANCIAL OFFICER | Purchase | +10,000 | +100.00%10,000 | $8.87 | $88,700 | View SEC filing | |
| 2021-06-10 | Gros David-Alexandre C Chief Executive Officer | Purchase | +3,000 | +100.00%3,000 | $8.01 | $24,030 | View SEC filing | |
| 2020-12-04 | OrbiMed Israel GP Ltd. 10% Owner | Sale | -103,200 | -58.35%73,650 | $21.60 | $2,229,120 | View SEC filing | |
| 2020-11-06 | Logos Global Management LP 10% Owner | Mixed | +79,071 | +54.53%224,071 | $25.59 | $2,687,272 | View SEC filing | |
| 2020-02-25 | OrbiMed Israel GP Ltd. Director, 10% Owner | Sale | +1,292,408 | N/A | $0.20 | $258,482 | View SEC filing | |
| 2020-02-25 | Chimovits Erez Director, 10% Owner | Sale | +1,292,408 | +68.35%3,183,314 | $0.20 | $258,482 | View SEC filing | |
| 2019-05-22 | TURKEL CATHERINE C. President | Sale | -9,537 | -9.71%88,662 | $1.95 | $18,612 | View SEC filing | |
| 2019-05-22 | Kuwahara Jon See Remarks | Sale | -5,276 | -46.90%5,974 | $1.95 | $10,296 | View SEC filing | |
| 2019-05-22 | FLESHER GREGORY J. Chief Executive Officer | Sale | -14,638 | -8.53%156,918 | $1.95 | $28,566 | View SEC filing | |
| 2019-05-06 | OrbiMed Israel GP Ltd. Director, 10% Owner | Purchase | +1,938,612 | +50.94%3,829,518 | $1.03 | $2,003,232 | View SEC filing | |
| 2019-05-06 | Chimovits Erez Director | Purchase | +1,938,612 | +50.94%3,829,518 | $1.03 | $2,003,232 | View SEC filing | |
| 2019-05-02 | LIFESCI INDEX PARTNERS LLC 10% Owner | Sale | -200 | -0.02%1,065,867 | $2.70 | $540 | View SEC filing | |
| 2018-09-13 | TURKEL CATHERINE C. President | Purchase | +33,680 | +75.65%78,199 | $4.78 | $161,147 | View SEC filing | |
| 2018-09-07 | TURKEL CATHERINE C. President | Purchase | +805 | +100.00%805 | $3.97 | $3,193 | View SEC filing | |
| 2017-05-11 | FLESHER GREGORY J. Chief Executive Officer | Purchase | +58,959 | +103.62%115,856 | $9.99 | $589,000 | View SEC filing | |
| 2017-05-11 | TURKEL CATHERINE C. Chief Development Officer | Purchase | +11,111 | +82.87%24,519 | $9.99 | $110,999 | View SEC filing | |
| 2017-05-11 | OCAMPO CHRISTINE See Remarks | Purchase | +10,010 | +86.44%21,590 | $9.99 | $100,000 | View SEC filing | |
| 2016-03-15 | Buckley Stephen Jr. Director | Purchase | +8,000 | +266.67%11,000 | $5.74 | $45,920 | View SEC filing | |
| 2015-11-12 | Buckley Stephen Jr. Director | Purchase | +3,000 | +100.00%3,000 | $11.25 | $33,750 | View SEC filing |
1-25 of 43